CYP2D6 gene polymorphism in psychiatric patients resistant to standard pharmacotherapy

被引：0
|
作者：
Zabrocka, M
Woszczek, G
Kowalski, ML
Borowiec, M
Zaborowski, A
机构：
[1] MED UNIV LODZ,DEPT PSYCHIAT 1,LODZ,POLAND
[2] MED UNIV LODZ,DEPT CLIN IMMUNOL & ALLERGY,LODZ,POLAND
来源：
AMERICAN JOURNAL OF MEDICAL GENETICS | 1997年 / 74卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：634 / 634
页数：1
相关论文
共 50 条
  • [1] CYP2D6 genotype polymorphism: tailored treatments in psychiatric patients
    La Montagna, M.
    Stella, E.
    Seripa, D.
    Miscio, G.
    Rinaldi, A.
    Bellomo, A.
    Lozupone, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S167 - S167
  • [2] PNAT AND CYP2D6 GENE POLYMORPHISM IN EPILEPTIC PATIENTS
    BORLAK, JT
    HARSANY, V
    SCHNEBLE, H
    HAEGELE, KD
    BIOCHEMICAL PHARMACOLOGY, 1994, 48 (09) : 1717 - 1720
  • [3] CYP2D6 gene test in psychiatric patients and healthy volunteers
    Rasmussen, JO
    Christensen, M
    Svendsen, JM
    Skausig, O
    Hansen, EL
    Nielsen, KA
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2006, 66 (02): : 129 - 136
  • [4] Effect of CYP2D6*10 polymorphism on mirtazapine metabolism in Japanese psychiatric patients
    Watanabe, T.
    Hyashi, Y.
    Aoki, A.
    Ishiguro, S.
    Inoue, Y.
    Akiyama, K.
    Tsuchimine, S.
    Yasui-Furukori, N.
    Shimoda, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S462 - S463
  • [5] CYP2D6 polymorphism in patients with eating disorders
    E M Peñas-LLedó
    P Dorado
    Z Agüera
    M Gratacós
    X Estivill
    F Fernández-Aranda
    A LLerena
    The Pharmacogenomics Journal, 2012, 12 : 173 - 175
  • [6] Clinical relevance of the CYP2D6 polymorphism for the treatment of psychiatric disorders
    Bertilsson, L
    PHARMACOGENETICS - TAILOR-MADE PHARMACOTHERAPY, 2002, 1244 : 11 - 20
  • [7] CYP2D6 polymorphism in patients with eating disorders
    Penas-LLedo, E. M.
    Dorado, P.
    Agueera, Z.
    Gratacos, M.
    Estivill, X.
    Fernandez-Aranda, F.
    LLerena, A.
    PHARMACOGENOMICS JOURNAL, 2012, 12 (02): : 173 - 175
  • [8] The impact of the CYP2D6 gene polymorphism on the risk of pemphigoid
    Rychlik-Sych, Mariola
    Baranska, Malgorzata
    Wojtczak, Anna
    Skretkowicz, Jadwiga
    Zebrowska, Agnieszka
    Waszczykowska, Elzbieta
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (12) : 1396 - 1401
  • [9] The Impact of the CYP2D6 "Enhancer" Single Nucleotide Polymorphism on CYP2D6 Activity
    Dinh, Jean C.
    Boone, Erin C.
    Staggs, Vincent S.
    Pearce, Robin E.
    Wang, Wendy Y.
    Gaedigk, Roger
    Leeder, James Steven
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (03) : 646 - 654
  • [10] CYP2D6 phenotyping of psychiatric patients and healthy subjects
    Lohmann, P
    Bagli, M
    Mörlke, K
    Laux, G
    Kolbinger, M
    Rao, ML
    PSYCHOPHARMAKOTHERAPIE, 1999, 6 (02): : 64 - 66
12345